New study: Erectile Dysfunction Analysis and In-depth Research on Market Size, Share, Trends, Emerging Growth

Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a ratio of about 5% at the age of 50 to 15% at 70 years. Even though this is a common condition, related to both age and secondary medical conditions like diabetes, hypertension, dyslipedemia, depression and cardiovascular disease, there were treatments conducted in the past by mostly andrologists, urologists and sex therapists. There has been a revolutionary introduction of oral drug therapy to treat erectile dysfunction and the enormous studies concerning erectile dysfunction has led to a paradigm shift in erectile dysfunction treatment.

According to study conducted by Canadian Institute of Health Research, there were about 4,000 Canadian men between the age 40 and 88 years, nearly half of them had erectile dysfunction. It was about approximately two times more usual in men with cardiovascular disease and four times more usual among men suffering with any kind of diabetes. Increase in the number of erectile dysfunction cases has led to an increase in the Cialis drugs, proportionally boost the erectile dysfunction market.

Download PDF Brochure@ https://www.coherentmarketinsights.com/insight/request-pdf/200

Erectile dysfunction is a sexual disorder characterized by the failure of a male individual to develop and maintain an erection of the penis during coitus. A penile erection is the process affecting the blood flow and reserve in sponge-like bodies within the penis. This causes arterial dilation, trabecular smooth muscle relaxation, and activation of the corporeal veno-occlusive mechanism. According to a Massachusetts Male Aging Study (MMAS) conducted by the European Association in 2015, the incidence of erectile dysfunction is 52% in non-institutionalized men in the urban and rural areas of Boston. In a cohort study by the MMAS, it was observed that one in four men seeking medical help for treating erectile dysfunction is above 40 years of age, with nearly 50% diagnosed with severe erectile dysfunction.

Market Dynamics

North America and Asia Pacific are the largest markets for erectile dysfunction products, as these regions have the highest prevalence of erectile dysfunction. For instance in the year 2012, according to The Massachusetts study, approximately 19,372 new cases of erectile dysfunction in Massachusetts and more than 721,615 cases in the United States yearly. China has a prevalence percentage of about 42.3 in the year 2011. There are many studies conducted to develop medication and medical devices to treat erectile dysfunction. According to the National Institutes of Health, over 30 million men over 75 years of age suffer from erectile dysfunction in the U.S. The Multinational Survey on the Aging Male (MSAM) study conducted in the U.S. and in European countries such as France, Germany, Italy, Netherlands, Spain, and the U.K. arrived at an unexplained relationship between lower urinary tract symptoms and sexual dysfunction in over 12 thousand men in the age group of 50-80 years. Of the 83% of the male population that was surveyed, who claimed to be sexually-active all the time, overall prevalence of lower urinary tract symptoms was 90%, with an overall incidence of erectile dysfunction pegged at 50%, and 10% of patients reported a complete absence of erection. Moreover, the overall incidence of ejaculation disorders was 46%.

Erectile Dysfunction Market Taxonomy

This report segments the global erectile dysfunction market on the basis of product, end user and geography. On the basis of product, the market is categorized into Viagra, Cialis, Stendra/ Spedra, Levitra, Zydena, and Vitaros. On the basis of end user, the market is categorized into hospitals, laboratories, homecare diagnostics, research institutes, and others. For comprehensive understanding of market dynamics, the global erectile dysfunction market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Request for Customization@ https://www.coherentmarketinsights.com/insight/request-customization/200

Key features of the study:

This report provides in-depth analysis of the erectile dysfunction market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global erectile dysfunction market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Meda Pharmaceuticals, Inc., Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical System, Boston Scientific Corporation, and Vivus, Inc.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics

The global erectile dysfunction market report caters to various stakeholders in this industry, including investors, drug manufacturers, distributors and suppliers for erectile dysfunction products, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the erectile dysfunction market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Erectile Dysfunction Market, By Product:
Viagra (Sildenafil citrate)
Cialis (Tadalafil)
Stendra/Spedra
Levitra/Staxyn
Zydena (Udenafil)
Vitaros (Alprostadil Cream)

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.